Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NexusPharma logo — We are dedicated to the discovery of novel therapeutics by c...

NexusPharma

We are dedicated to the discovery of novel therapeutics by creating and testing patient derived cancer xenograft

Founded 2004 United States Hamilton, United States 3 employees Seed Biotechnology, Health Care +1

General Information

Company Name NexusPharma
Founded Year 2004
Location United States Hamilton, United States
Employees 3
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with NexusPharma. To contact NexusPharma, visit nexuspharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NexusPharma compare?

A PDF of NexusPharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NexusPharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NexusPharma

Cancer is the second leading cause of death in the United States, and there is a continuing need to provide new, safer cancer drugs to patients. We at NexusPharma, a Genesis Drug Discovery and Development (GD3) Member Company, actively pursue this unmet need to provide effective discovery tools to select novel therapeutics with fewer side effects for cancer patients. Together with Fox Chase Cancer Center, a company co-founder, we are dedicated to developing patient-derived tumor disease models to advance the discovery of effective drugs.

No funding data available for NexusPharma yet.

NexusPharma Alternatives & Competitors

View All Alternatives
NexusPharma vs
Nanoligent
Nanoligent Spain

Our mision is to improve the life of patients by designing new drugs that selectively target affecte...

Seed
15 employees
Biotechnology, Pharmaceutical
NexusPharma vs
Healx
Healx United Kingdom

AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treat...

Growth
71 employees
AI, Biopharma
NexusPharma vs
Apollomics
Apollomics United States

We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...

Post-IPO Equity
26 employees
Biotechnology, Health Care
View all alternatives

FAQ About NexusPharma

We are dedicated to the discovery of novel therapeutics by creating and testing patient derived cancer xenograft
NexusPharma was founded in 2004.
NexusPharma is headquartered in Hamilton, United States.
NexusPharma operates in Biotechnology, Health Care and Pharmaceutical.
NexusPharma has approximately 3 employees.
Top alternatives and competitors to NexusPharma include Nanoligent, Healx, Apollomics, Creative BioTherapeutics LLC, Altis Biosystems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NexusPharma and Nanoligent are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NexusPharma, https://bouncewatch.com/company/nexuspharma, updated 3 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes